Curis (CRIS) Other financing activities (2013 - 2020)

Curis (CRIS) reported Other financing activities of $1.3 million for Q4 2020, up 249.94% quarter-over-quarter from -$849000.0 in Q3 2020.

Curis (CRIS) Other financing activities (2013 - 2020) Analysis & Trends

Curis has reported Other financing activities for 4 years, with the latest figure at $1.3 million in Q4 2020.

For the quarter ending Q4 2020, Other financing activities changed N/A year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2021 stood at $424000.0 (changed 0.0% YoY), and the FY2020 full-year result was $1.5 million, changed N/A from the prior year.
Other financing activities for Q4 2020 stood at $1.3 million, up from -$849000.0 in the prior quarter.
The five-year high for Other financing activities was $1.3 million in Q4 2020, with the low at -$849000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Curis	8.58 Mn	-6.42 Mn	-

Download Data